✦ LIBER ✦

Computed tomography (CT) evaluation of breast cancer patients with osteolytic bone metastases undergoing palliative radiotherapy—a feasibility study

✍ Scribed by Edward Chow; Lori Holden; Joel Rubenstein; Monique Christakis; Katharina Sixel; Marjan Vidmar; Joel Finkelstein; Charles Hayter; Andrew Loblaw; Rebecca Wong; Ewa Szumacher; Cyril Danjoux

Book ID: 118496221
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 82 KB
Volume: 70
Category: Article
ISSN: 0167-8140
DOI: 10.1016/j.radonc.2004.01.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluating remineralization in breast ca

Evaluating remineralization in breast cancer patients with osteolytic bone metastases undergoing palliative radiotherapy using computerized tomography (CT) density measurements — a feasibility study

✍ L Holden; J Rubenstein; M Christakis; C Danjoux; K Sixel; M Vidmar; R Connolly; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 29 KB

76 Evaluating remineralization in breast

76 Evaluating remineralization in breast cancer patients with osteolytic bones metastases undergoing palliative radiotherapy using Computerized Tomography (CT) density measurements — a feasibility study

📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 154 KB

Zoledronic acid concurrent with either h

Zoledronic acid concurrent with either high- or reduced-dose palliative radiotherapy in the management of the breast cancer patients with bone metastases: a phase IV randomized clinical study

✍ Lale Atahan; Ferah Yıldız; Mustafa Cengiz; Bunyamin Kaplan; Metin Özkan; Gozde Y 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 349 KB

PP-8-9 Reduction of skeletal related com

PP-8-9 Reduction of skeletal related complications in breast cancer patients with osteolytic bone metastases receiving chemotherapy (CT), by monthly pamidronate sodium (PAM) (AREDIA®) infusion

✍ G.N. Hortobagyi; L Porter; D. Blayney; R.L Theriault; A. Lipton; S. Gluck; H. Wh 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 179 KB

Phase II Trial Evaluating the Palliative

Phase II Trial Evaluating the Palliative Benefit of Second-Line Zoledronic Acid in Breast Cancer Patients With Either a Skeletal-Related Event or Progressive Bone Metastases Despite First-Line Bisphosphonate Therapy

✍ Brufsky, A.M. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 60 KB

A phase II trial evaluating the palliati

A phase II trial evaluating the palliative benefit of second-line zoledronic acid in breast cancer patients with either a skeletal related event (SRE) or progressive bone metastases despite standard bisphosphonate (BP) therapy

✍ M. Clemons; G. Dranitsaris; W.S. Ooi; D.E.C. Cole 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 51 KB